Skip to main content

Table 1 Patients and tumor characteristics

From: Impact of tumor attachment to the pleura measured by a pretreatment CT image on outcome of stage I NSCLC treated with stereotactic body radiotherapy

Characteristic

No. (%)

Age, median, years

78 (range: 48-92)

Gender

 

 Female

19 (21)

 Male

68 (78)

ECOG performance status

 

 0-1

71 (81)

 2

12 (13)

 3

4 (4)

Tumor diameter, median, cm

2.2 (range: 0.9-4.2)

 ≤ 2.0

38 (42)

 2.1-3.0

40 (44)

 3.1-5.0

12 (13)

Pathology

 

 Adenocarcinoma

32 (35)

 Squamous cell carcinoma

20 (22)

 Others

8 (8)

 Clinically diagnosed

30 (33)

SBRT dose, BED10

 

 ≤ 102 Gy10

44 (48)

 > 102 Gy10

46 (51)

Prescription

 

 Isocenter

59 (65)

 D95

31 (34)

  1. Data are shown as number (percentage) of patients for parameters from age to performance status and as number (percentage) of tumors for other parameters.
  2. Abbreviations: ECOG, Eastern cooperative oncology group; BED10, biological effective dose, calculated by the formula BED = nd [1 + d/(α/β)], where n is the number of fractions, d is the dose/fraction, and α/β ratio is 10 Gy for tumors; D95, doses covering 95% of the planning target volume.